Thomas Denize

2.3k total citations
27 papers, 322 citations indexed

About

Thomas Denize is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Molecular Biology. According to data from OpenAlex, Thomas Denize has authored 27 papers receiving a total of 322 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Pulmonary and Respiratory Medicine, 12 papers in Oncology and 11 papers in Molecular Biology. Recurrent topics in Thomas Denize's work include Renal cell carcinoma treatment (11 papers), Cancer Immunotherapy and Biomarkers (7 papers) and Renal and related cancers (5 papers). Thomas Denize is often cited by papers focused on Renal cell carcinoma treatment (11 papers), Cancer Immunotherapy and Biomarkers (7 papers) and Renal and related cancers (5 papers). Thomas Denize collaborates with scholars based in United States, France and Italy. Thomas Denize's co-authors include Sabina Signoretti, Cécile Badoual, Jérémy Augustin, Éric Tartour, Kun‐Hsing Yu, Jeffrey A. Golden, Emily Walton, Eliana Marostica, Isaac S. Kohane and H. Mirghani and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Nature Communications and Journal of Clinical Oncology.

In The Last Decade

Thomas Denize

26 papers receiving 319 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Thomas Denize United States 12 133 129 121 98 55 27 322
Carrie B. Marshall United States 11 129 1.0× 94 0.7× 140 1.2× 69 0.7× 117 2.1× 20 397
Franz J. Hilke Germany 10 68 0.5× 62 0.5× 114 0.9× 89 0.9× 28 0.5× 15 276
Haohua Teng China 13 172 1.3× 61 0.5× 92 0.8× 51 0.5× 59 1.1× 28 301
Cédric van Marcke Belgium 12 92 0.7× 124 1.0× 156 1.3× 165 1.7× 18 0.3× 34 370
Niko Kemi Finland 10 115 0.9× 57 0.4× 134 1.1× 62 0.6× 84 1.5× 14 296
Binnari Kim South Korea 11 122 0.9× 66 0.5× 141 1.2× 71 0.7× 71 1.3× 29 289
Yae‐Eun Suh United Kingdom 9 98 0.7× 188 1.5× 117 1.0× 139 1.4× 57 1.0× 16 389
Jacqueline Siok Gek Hwang Singapore 11 73 0.5× 107 0.8× 148 1.2× 54 0.6× 134 2.4× 25 405
Gaetano Paolino Italy 11 49 0.4× 54 0.4× 233 1.9× 83 0.8× 97 1.8× 19 308
Junmiao Wen China 11 209 1.6× 50 0.4× 124 1.0× 36 0.4× 97 1.8× 33 336

Countries citing papers authored by Thomas Denize

Since Specialization
Citations

This map shows the geographic impact of Thomas Denize's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Thomas Denize with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Thomas Denize more than expected).

Fields of papers citing papers by Thomas Denize

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Thomas Denize. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Thomas Denize. The network helps show where Thomas Denize may publish in the future.

Co-authorship network of co-authors of Thomas Denize

This figure shows the co-authorship network connecting the top 25 collaborators of Thomas Denize. A scholar is included among the top collaborators of Thomas Denize based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Thomas Denize. Thomas Denize is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Morgan, Paul, Thomas Denize, Sachet A. Shukla, et al.. (2025). 831 AXL Receptor Tyrosine Kinase Expression in Metastatic Renal Cell Carcinoma: Insights from the METEOR trial. Laboratory Investigation. 105(3). 103064–103064. 1 indexed citations
2.
Denize, Thomas, Maxine Sun, Renée Maria Saliby, et al.. (2024). Expression of the receptor tyrosine kinase AXL and clinical outcomes to cabozantinib and everolimus in patients with metastatic renal cell carcinoma enrolled in the METEOR trial.. Journal of Clinical Oncology. 42(16_suppl). 4543–4543. 2 indexed citations
3.
Garinet, Simon, Audrey Lupo, Thomas Denize, et al.. (2024). Successive next-generation sequencing strategy for optimal fusion gene detection in non-small-cell lung cancer in clinical practice. Pathology. 56(5). 702–709. 2 indexed citations
4.
Einstein, David J., Brian Halbert, Thomas Denize, et al.. (2024). Generation and Characterization of Ex Vivo Expanded Tumor-infiltrating Lymphocytes From Renal Cell Carcinoma Tumors for Adoptive Cell Therapy. Journal of Immunotherapy. 47(9). 361–368. 3 indexed citations
5.
Atkins, Michael B., Opeyemi A. Jegede, Naomi B. Haas, et al.. (2023). Phase II study of nivolumab and salvage nivolumab/ipilimumab in treatment-naïve patients with advanced non-clear cell renal cell carcinoma (HCRN GU16-260-Cohort B). Journal for ImmunoTherapy of Cancer. 11(3). e004780–e004780. 19 indexed citations
6.
Denize, Thomas, Catherine B. Meador, Jaimie L. Barth, et al.. (2023). Concordance of ASCL1, NEUROD1 and POU2F3 transcription factor‐based subtype assignment in paired tumour samples from small cell lung carcinoma. Histopathology. 83(6). 912–924. 6 indexed citations
7.
Moore, Kevin J., et al.. (2023). Cutaneous angiosarcoma of the scalp in a pediatric patient with xeroderma pigmentosum. JAAD Case Reports. 41. 37–39. 1 indexed citations
8.
Nyman, Jackson, Thomas Denize, Ziad Bakouny, et al.. (2023). Spatially aware deep learning reveals tumor heterogeneity patterns that encode distinct kidney cancer states. Cell Reports Medicine. 4(9). 101189–101189. 14 indexed citations
9.
Li, Annie, Julia Thierauf, Atul K. Bhan, et al.. (2023). 102 Immune landscape of adenoid cystic carcinoma using multiplex immunofluorescence and digital pathology. SHILAP Revista de lepidopterología. A116–A116. 1 indexed citations
10.
Denize, Thomas, Yue Hou, Jean‐Christophe Pignon, et al.. (2022). Transcriptomic Correlates of Tumor Cell PD-L1 Expression and Response to Nivolumab Monotherapy in Metastatic Clear Cell Renal Cell Carcinoma. Clinical Cancer Research. 28(18). 4045–4055. 13 indexed citations
11.
Stransky, Laura, et al.. (2022). Sensitivity ofVHLmutant kidney cancers to HIF2 inhibitors does not require an intact p53 pathway. Proceedings of the National Academy of Sciences. 119(14). e2120403119–e2120403119. 21 indexed citations
12.
Marostica, Eliana, Thomas Denize, Isaac S. Kohane, et al.. (2021). Development of a Histopathology Informatics Pipeline for Classification and Prediction of Clinical Outcomes in Subtypes of Renal Cell Carcinoma. Clinical Cancer Research. 27(10). 2868–2878. 40 indexed citations
13.
Denize, Thomas, Subrina Farah, Alessia Cimadamore, et al.. (2021). Biomarkers of Angiogenesis and Clinical Outcomes to Cabozantinib and Everolimus in Patients with Metastatic Renal Cell Carcinoma from the Phase III METEOR Trial. Clinical Cancer Research. 28(4). 748–755. 12 indexed citations
14.
Garinet, Simon, Audrey Didelot, Thomas Denize, et al.. (2021). Clinical assessment of the miR-34, miR-200, ZEB1 and SNAIL EMT regulation hub underlines the differential prognostic value of EMT miRs to drive mesenchymal transition and prognosis in resected NSCLC. British Journal of Cancer. 125(11). 1544–1551. 20 indexed citations
15.
Denize, Thomas, Mathilde Sibony, Hélène Blons, et al.. (2020). MET alterations in biphasic squamoid alveolar papillary renal cell carcinomas and clinicopathological features. Modern Pathology. 34(3). 647–659. 18 indexed citations
16.
Verkarre, Virginie, et al.. (2020). Les cancers du rein héréditaires vus par le pathologiste en 2020. Annales de Pathologie. 40(2). 148–167. 10 indexed citations
17.
Bertheau, Philippe, Thomas Denize, Nicolas Poté, et al.. (2019). Pédagogie à grande échelle en ACP. Annales de Pathologie. 39(2). 144–150. 3 indexed citations
18.
Augustin, Jérémy, et al.. (2019). Chromogenic In Situ Hybridization as a Tool for HPV-Related Head and Neck Cancer Diagnosis. Journal of Visualized Experiments. 4 indexed citations
19.
Augustin, Jérémy, Marion Mandavit, H. Mirghani, et al.. (2018). HPV RNA CISH score identifies two prognostic groups in a p16 positive oropharyngeal squamous cell carcinoma population. Modern Pathology. 31(11). 1645–1652. 15 indexed citations
20.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Carrie B. Marshall Breakdown of academic impact, for papers by Franz J. Hilke Breakdown of academic impact, for papers by Haohua Teng Breakdown of academic impact, for papers by Cédric van Marcke Breakdown of academic impact, for papers by Niko Kemi Breakdown of academic impact, for papers by Binnari Kim Breakdown of academic impact, for papers by Yae‐Eun Suh Breakdown of academic impact, for papers by Jacqueline Siok Gek Hwang Breakdown of academic impact, for papers by Gaetano Paolino Breakdown of academic impact, for papers by Junmiao Wen
Rankless by CCL
2026